BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 28389225)

  • 1. Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study.
    Çolak Y; Afzal S; Nordestgaard BG; Vestbo J; Lange P
    Lancet Respir Med; 2017 May; 5(5):426-434. PubMed ID: 28389225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.
    Lange P; Çolak Y; Ingebrigtsen TS; Vestbo J; Marott JL
    Lancet Respir Med; 2016 Jun; 4(6):454-62. PubMed ID: 27061878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study.
    Thomsen M; Nordestgaard BG; Vestbo J; Lange P
    Lancet Respir Med; 2013 Sep; 1(7):543-50. PubMed ID: 24461615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High body mass index and risk of exacerbations and pneumonias in individuals with chronic obstructive pulmonary disease: observational and genetic risk estimates from the Copenhagen General Population Study.
    Çolak Y; Afzal S; Lange P; Nordestgaard BG
    Int J Epidemiol; 2016 Oct; 45(5):1551-1559. PubMed ID: 27118560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry.
    McKleroy W; Shing T; Anderson WH; Arjomandi M; Awan HA; Barjaktarevic I; Barr RG; Bleecker ER; Boscardin J; Bowler RP; Buhr RG; Criner GJ; Comellas AP; Curtis JL; Dransfield M; Doerschuk CM; Dolezal BA; Drummond MB; Han MK; Hansel NN; Helton K; Hoffman EA; Kaner RJ; Kanner RE; Krishnan JA; Lazarus SC; Martinez FJ; Ohar J; Ortega VE; Paine R; Peters SP; Reinhardt JM; Rennard S; Smith BM; Tashkin DP; Couper D; Cooper CB; Woodruff PG
    JAMA; 2023 Aug; 330(5):442-453. PubMed ID: 37526720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, Characteristics, and Prognosis of Early Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study.
    Çolak Y; Afzal S; Nordestgaard BG; Vestbo J; Lange P
    Am J Respir Crit Care Med; 2020 Mar; 201(6):671-680. PubMed ID: 31770495
    [No Abstract]   [Full Text] [Related]  

  • 8. Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study.
    Gedebjerg A; Szépligeti SK; Wackerhausen LH; Horváth-Puhó E; Dahl R; Hansen JG; Sørensen HT; Nørgaard M; Lange P; Thomsen RW
    Lancet Respir Med; 2018 Mar; 6(3):204-212. PubMed ID: 29331311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low concentrations of 25-hydroxyvitamin D and long-term prognosis of COPD: a prospective cohort study.
    Færk G; Çolak Y; Afzal S; Nordestgaard BG
    Eur J Epidemiol; 2018 Jun; 33(6):567-577. PubMed ID: 29691706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting exacerbations in COPD in the Danish general population.
    Marott JL; Ingebrigtsen TS; Çolak Y; Vestbo J; Nordestgaard BG; Lange P
    Respir Med; 2024 Apr; 224():107557. PubMed ID: 38355020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood eosinophil count and risk of pneumonia hospitalisations in individuals with COPD.
    Vedel-Krogh S; Nordestgaard BG; Lange P; Vestbo J; Nielsen SF
    Eur Respir J; 2018 May; 51(5):. PubMed ID: 29650563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of Early COPD in Young Adults for Development of Clinical COPD: Findings from the Copenhagen General Population Study.
    Çolak Y; Afzal S; Nordestgaard BG; Lange P; Vestbo J
    Am J Respir Crit Care Med; 2021 May; 203(10):1245-1256. PubMed ID: 33142077
    [No Abstract]   [Full Text] [Related]  

  • 13. Majority of never-smokers with airflow limitation do not have asthma: the Copenhagen General Population Study.
    Çolak Y; Afzal S; Nordestgaard BG; Lange P
    Thorax; 2016 Jul; 71(7):614-23. PubMed ID: 27015799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of chronic respiratory symptoms in individuals with normal spirometry.
    Çolak Y; Nordestgaard BG; Vestbo J; Lange P; Afzal S
    Eur Respir J; 2019 Sep; 54(3):. PubMed ID: 31248954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study.
    Vedel-Krogh S; Nielsen SF; Lange P; Vestbo J; Nordestgaard BG
    Am J Respir Crit Care Med; 2016 May; 193(9):965-74. PubMed ID: 26641631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of Patients with Chronic Obstructive Pulmonary Disease Not Eligible for Major Clinical Trials.
    Çolak Y; Nordestgaard BG; Lange P; Vestbo J; Afzal S
    Am J Respir Crit Care Med; 2022 Aug; 206(3):271-280. PubMed ID: 35438616
    [No Abstract]   [Full Text] [Related]  

  • 17. Socioeconomic status and prognosis of COPD in Denmark.
    Lange P; Marott JL; Vestbo J; Ingebrigtsen TS; Nordestgaard BG
    COPD; 2014 Aug; 11(4):431-7. PubMed ID: 24568315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ratio of FEV
    Fortis S; Comellas AP; Bhatt SP; Hoffman EA; Han MK; Bhakta NR; Paine R; Ronish B; Kanner RE; Dransfield M; Hoesterey D; Buhr RG; Barr RG; Dolezal B; Ortega VE; Drummond MB; Arjomandi M; Kaner RJ; Kim V; Curtis JL; Bowler RP; Martinez F; Labaki WW; Cooper CB; O'Neal WK; Criner G; Hansel NN; Krishnan JA; Woodruff P; Couper D; Tashkin D; Barjaktarevic I
    Chest; 2021 Jul; 160(1):94-103. PubMed ID: 33539837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
    Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort.
    van Dijk W; Tan W; Li P; Guo B; Li S; Benedetti A; Bourbeau J;
    Ann Fam Med; 2015; 13(1):41-8. PubMed ID: 25583891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.